Loading
Non-tailored lung screening / LungTalk / Lung Cancer · Interventional Study
ClinicalTrials.gov · September 8, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a planned pilot hybrid trial examining the reach and preliminary effectiveness of a tailored lung screening intervention (LungTalk) delivered in the ED compared to enhanced usual care. No results are yet reported in this registry record. The study aims to assess lung screening uptake and stages of adoption in screening-eligible patients identified via EHR-embedded SDoH screening.
Interventional, Randomized, Parallel, Open label, Screening purpose. Lung Cancer; age from 50 Years; to 80 Years. Intervention: LungTalk Group. Compared with: Non-tailored Lung Screening Pamphlet Group — Active Comparator. n = 100. 10 sites: United States.
This is a planned pilot hybrid trial examining the reach and preliminary effectiveness of a tailored lung screening intervention (LungTalk) delivered in the ED compared to enhanced usual care. No results are yet reported in this registry record. The study aims to assess lung screening uptake and stages of adoption in screening-eligible patients identified via EHR-embedded SDoH screening.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
This is a pilot Type 1 Hybrid Effectiveness-Implementation Trial still in recruitment phase with no posted results; it will examine reach and preliminary effectiveness of a tailored lung screening intervention in an ED setting.
As stated by the source record.
Quoted from the source exactly as published.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT06605534). This is a study registration, not published results. Lead sponsor: Hackensack Meridian Health. Recruitment status: RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 100 participants (ESTIMATED). Conditions: Lung Cancer. Interventions: BEHAVIORAL: LungTalk; OTHER: Non-tailored lung screening. Primary outcome measures: Lung Cancer Screening Uptake , Assessed at 1 month and 6 months post intervention; Stage of Adoption for Lung Cancer Screening , Assessed at 1 week and then at 1 month and 6 months post intervention. Brief summary: This is a pilot Type 1 Hybrid Effectiveness-Implementation Trial. The study will first examine reach in a non-traditional setting (the Emergency Department - ED) that uses an Electronic Health Record (EHR)-embedded Social Determinants of Health (SDoH) screening tool to identify lung screening-eligible patients for a tailored intervention to increase lung screening uptake. Reach is defined as the absolute number, proportion, and representativeness of individuals targeted for lung screening knowledge, awareness, and uptake. Then, a pilot trial will be conducted to examine the preliminary effectiveness of a tailored lung screening intervention compared to enhanced usual care to influence individual-level potential drivers of lung screening (health literacy, mistrust, stigma, fatalism, knowledge, lung screening health beliefs) and the ability to increase lung screening uptake among screening-eligible patients. Quantitative (Randomized Controlled Trial and EHR data) methods will be used for data collection and analysis to address the study aims.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.